A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine
Clinical trial NCT02575456 · COMPLETED
Trial details
- NCT number
- NCT02575456
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-06-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.